Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Jul 5, 2022
Filed with the SEC on Jul 5, 2022 and accepted by EDGAR at Jul 5, 2022, 16:08 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 1.02 Termination of a material agreement
- Item 2.03 New direct financial obligation
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000875320-22-000019. Last ingested by Listed: Nov 6, 2026, 12:56 ET. Listed shows no prices and gives no investment advice.